A Single-Ascending-Dose Study of MK6916 in Healthy Participants
MK-6916-001
Phase 1 other active
Quick answer
A Single-Ascending-Dose Study of MK6916 in Healthy Participants for Acute and chronic Pain is a Phase 1 program (other) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Acute and chronic Pain
- Phase
- Phase 1
- Modality
- other
- Status
- active